- Home
- BCRX vs ARRY Comparison
BCRX vs ARRY Comparison
Compare BCRX & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- ARRY
- Stock Information
- Founded
- BCRX 1986
- ARRY 1989
- Country
- BCRX United States
- ARRY United States
- Employees
- BCRX N/A
- ARRY N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- ARRY Semiconductors
- Sector
- BCRX Health Care
- ARRY Technology
- Exchange
- BCRX Nasdaq
- ARRY Nasdaq
- Market Cap
- BCRX 1.4B
- ARRY 1.3B
- IPO Year
- BCRX 1994
- ARRY 2020
- Fundamental
- Price
- BCRX $6.87
- ARRY $8.25
- Analyst Decision
- BCRX Strong Buy
- ARRY Buy
- Analyst Count
- BCRX 11
- ARRY 20
- Target Price
- BCRX $19.00
- ARRY $9.92
- AVG Volume (30 Days)
- BCRX 7.8M
- ARRY 6.5M
- Earning Date
- BCRX 11-03-2025
- ARRY 11-05-2025
- Dividend Yield
- BCRX N/A
- ARRY N/A
- EPS Growth
- BCRX N/A
- ARRY N/A
- EPS
- BCRX N/A
- ARRY N/A
- Revenue
- BCRX $599,816,000.00
- ARRY $1,333,329,000.00
- Revenue This Year
- BCRX $41.57
- ARRY $34.42
- Revenue Next Year
- BCRX $6.25
- ARRY $14.70
- P/E Ratio
- BCRX N/A
- ARRY N/A
- Revenue Growth
- BCRX 45.38
- ARRY 35.75
- 52 Week Low
- BCRX $6.00
- ARRY $3.76
- 52 Week High
- BCRX $11.31
- ARRY $10.37
- Technical
- Relative Strength Index (RSI)
- BCRX 43.58
- ARRY 45.37
- Support Level
- BCRX $6.51
- ARRY $7.70
- Resistance Level
- BCRX $7.22
- ARRY $9.40
- Average True Range (ATR)
- BCRX 0.27
- ARRY 0.59
- MACD
- BCRX 0.01
- ARRY -0.10
- Stochastic Oscillator
- BCRX 41.15
- ARRY 23.18
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About ARRY Array Technologies Inc.
Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.